TREM2 and Alzheimer disease: However, some essential questions for exploration include: (1) can TREM2 activation be maintained in the microglia of AD patients with mild dementia, and (2) can activated monocytes serve as a biomarker for microglial TREM2 activation in AD since they correlate with TREM2 status?